President Donald Trump said he plans to “impose” very soon “tariffs on drugs that can be the next stage of global trade inspection. Supporters argue that reducing US dependence on foreign suppliers is important for national security, but others are concerned that steep tariffs can raise the price of patients. Pharmaceuticals have been exempt from Trump’s mutual tariff package, and most of them are suspended for 90 days as the administration negotiates with the target country. The White House did not immediately respond to the email questions about the size and scope of the potential tariffs on pharmaceuticals. It is not clear when the income tax can be fermented at this time and which products can be saved. Promotion is part of Trump’s efforts to increase drug manufacturing in the US soil. Trump said on Wednesday, “We realized that we did not make drugs and constraints in this country.” “The only thing that can reclaim them is, ‘We have a barrier. We must pay 50 %, 100 % or 200 %.” Pharmaceutical trade group PHRMA refused an interview, but nearly two -thirds of the drugs taken by US patients are produced here. “We share the goal of President Trump’s US manufacturing revitalization,” said PHRMA’s vice president of Alex Schriver. Administration) said that the majority of the herbal ingredients are increasing in recent decades, especially the main player of Clarivate, “Henry Levy. It is being done in China. Levy said that the price of pharmaceuticals was set through complex negotiations with various stakeholders. This means that the potential consumer impact due to tariffs can take longer to realize it. “I think this can affect the availability of availability, which will affect the price next year, which will quickly affect profitability, and experts say that the increase in manufacturing costs can be potentially absorbed by drug manufacturers or insurance companies, which can also be delivered in the form of higher premiums and cofpeii. Patients with Merith Basey, director of Affordable Drugs, said, “One in three people can’t afford to fill the prescription today.” The dependence on the country, such as India and China, has also been able to increase the cost of the cost of about $ 750 million. There may be no. There are more important drugs than other drugs, and there are drugs that are made inside the United States or at least to produce inside North America.
President Donald Trump said he plans to “impose” very soon “tariffs on drugs that can be the next stage of global trade inspection.
Supporters argue that reducing US dependence on foreign suppliers is important for national security, but others are concerned that steep tariffs can raise the price of patients.
Pharmaceuticals have been exempted from Trump’s mutual tariff package, most of which are pause for 90 days as the administration negotiates with the target country.
The White House did not immediately respond to the email questions about the size and scope of the potential tariffs on pharmaceuticals. It is not clear when the income tax can be fermented at this time and which products can be saved.
Promotion is part of Trump’s efforts to increase drug manufacturing in the US soil.
Trump said on Wednesday, “We realized that we did not make drugs and constraints in this country.” “The only thing that can bring them back is, ‘We have a barrier. You must pay 50 %, 100 % or 200 %.”
Pharmaceutical Trade Group PhRMA refused to request an interview, but it stated that almost two -thirds of the drugs taken by US patients were produced here.
“We share President Trump’s goal of revitalizing US manufacturing in the United States,” said PHRMA’s vice president of Alex Schriver.
Food and Drug Administration says that the majority of herbal ingredients are increasing in recent decades, and are being manufactured abroad.
Europe, China and India are especially main players in relation to generic pharmaceuticals.
Henry Levy, the chairman of Clarivate’s Life Sciences and Health Management, said, “In some of the most important drugs, such as antibiotics, almost 100 %of them are in India and China.
Levy said that the price of pharmaceuticals was set through complex negotiations with various stakeholders. This means that the potential consumer impact due to tariffs can take longer to realize it.
Levy said, “I think this can affect availability, which will affect the price next year, which will quickly affect profitability.
Experts say the increase in manufacturing costs due to tariffs can be potentially absorbed by drug manufacturers or insurance companies. It can also be delivered in the form of higher premiums and cofpe.
Patients with Merith Basey, director of Affordable Drugs, said, “One in three people can’t afford to fill the prescription today.” “There is a concern that these tariffs will increase the cost of the patient and make their lives much more difficult.”
no way Recent study Examination of drugs used in the United States, which depends on Canadian manufacturing, warned that 25%of tariffs can increase the cost of 25%of $ 750 million and greatly interfere with supply in the long run.
MINA TADROUS, the author and assistant professor of Leslie dan Pharmacy at the University of Toronto, said he supports the mission to reduce Trump’s dependence on countries such as India and China. But he urged the administration to pursue more surgical solutions.
Tadrous said, “This intersection of tariffs may work, there are more important drugs than other drugs, and there are drugs that are made inside the United States or at least to produce inside North America.
